COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds. To help keep you informed, we’re releasing a special Q&A series with our experts to discuss the virus’s impact on each stage of the launch journey.
If you’d like to speak with us about how to plan your 3PL inspection process, get in touch.
Vice President of Specialty Distribution
Vice President of Client Services
How is COVID-19 impacting the manufacturer-3PL relationship?
Whether you’re still selecting your 3PLs or are fully operational with your partners, there may need to be some quick adjustments and decisions. If you find yourself in one of the situations below, Two Labs can provide guidance to keep your launch on time and your product moving.
Who are most at risk for seeing an impact on their 3PL process?
What is your advice for manufacturers at this time?
The good news is that this process can continue one way or another. Although it might look different with desktop audits and video calls, it’s possible to complete 3PL inspections in a timely manner, even during this outbreak. But it’s important not to overreact and rush the process.
Get on the Smartest Route to Your Pharma Product Journey with Two Labs
We Lead Pharma Manufacturers Through the Commercial Strategy and Operations Journey
We Have Deep Experience Supporting Pharma Manufacturers
New Product Launches
Years of Experience
Do you need help determining the impact of COVID-19 on your launch and how to navigate forward? Fill out the form below to get in touch with our expert team.